Education
About Us
Working with TipRanks
Follow Us
B.R.A.I.N. Biotechnology Research and Information Network AG (DE:BNN)
XETRA:BNN
RESEARCH TOOLSreports
Total Valuation
B.R.A.I.N. Biotechnology Research and Information Network has a market cap or net worth of €41.62M. The enterprise value is €90.94M.
Market Cap€41.62M
Enterprise Value€90.94M
Share Statistics
B.R.A.I.N. Biotechnology Research and Information Network has 21,847,494 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,847,494
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
B.R.A.I.N. Biotechnology Research and Information Network’s return on equity (ROE) is -0.88 and return on invested capital (ROIC) is -12.35%.
Return on Equity (ROE)-0.88
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-12.35%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee184.56K
Profits Per Employee-37.59K
Employee Count296
Asset Turnover0.62
Inventory Turnover2.59
Valuation Ratios
The current PE Ratio of B.R.A.I.N. Biotechnology Research and Information Network is -4.16. B.R.A.I.N. Biotechnology Research and Information Network’s PEG ratio is -0.58.
PE Ratio-4.16
PS Ratio0.00
PB Ratio3.25
Price to Fair Value3.67
Price to FCF-12.73
Price to Operating Cash Flow-64.88
PEG Ratio-0.58
Income Statement
In the last 12 months, B.R.A.I.N. Biotechnology Research and Information Network had revenue of 54.63M and earned -11.13M in profits. Earnings per share was -0.51.
Revenue54.63M
Gross Profit30.33M
Operating Income-8.85M
Pretax Income-10.99M
Net Income-11.13M
EBITDA-4.23M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -6.92M and capital expenditures -9.00K, giving a free cash flow of -8.65M billion.
Operating Cash Flow-6.92M
Free Cash Flow-8.65M
Free Cash Flow per Share-0.40
Dividends & Yields
B.R.A.I.N. Biotechnology Research and Information Network pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-10.98%
50-Day Moving Average2.06
200-Day Moving Average2.65
Relative Strength Index (RSI)40.86
Average Volume (3m)3.19K
Important Dates
B.R.A.I.N. Biotechnology Research and Information Network upcoming earnings date is Aug 28, 2025, Before Open (Confirmed).
Last Earnings DateMay 28, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
B.R.A.I.N. Biotechnology Research and Information Network as a current ratio of 1.83, with Debt / Equity ratio of 10.25%
Current Ratio1.83
Quick Ratio1.45
Debt to Market Cap0.24
Net Debt to EBITDA3.40
Interest Coverage Ratio-4.57
Taxes
In the past 12 months, B.R.A.I.N. Biotechnology Research and Information Network has paid 111.00K in taxes.
Income Tax111.00K
Effective Tax Rate-0.01
Enterprise Valuation
B.R.A.I.N. Biotechnology Research and Information Network EV to EBITDA ratio is -7.56, with an EV/FCF ratio of -6.01.
EV to Sales0.58
EV to EBITDA-7.56
EV to Free Cash Flow-6.01
EV to Operating Cash Flow-8.92
Balance Sheet
B.R.A.I.N. Biotechnology Research and Information Network has €0.00 in cash and marketable securities with €0.00 in debt, giving a net cash position of €0.00 billion.
Cash & Marketable Securities€0.00
Total Debt€0.00
Net Cash€0.00
Net Cash Per Share€0.00
Tangible Book Value Per Share-€0.01
Margins
Gross margin is 55.44%, with operating margin of -16.20%, and net profit margin of -20.37%.
Gross Margin55.44%
Operating Margin-16.20%
Pretax Margin-20.12%
Net Profit Margin-20.37%
EBITDA Margin-7.74%
EBIT Margin-16.57%
Analyst Forecast
The average price target for B.R.A.I.N. Biotechnology Research and Information Network is €6.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€6.90
Price Target Upside263.16% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-4.90%
EPS Growth Forecast-69.80%